Alcon and STAAR Surgical Announce Expiration of Hart-Scott-Rodino Waiting Period for Alcon's Acquisition of STAAR

Core Viewpoint - Alcon has successfully completed the waiting period for its acquisition of STAAR Surgical Company under the Hart-Scott-Rodino Antitrust Improvements Act, indicating progress in the acquisition process [1] Company Summary - Alcon is recognized as a global leader in eye care, focusing on enhancing vision for individuals [1] - STAAR Surgical Company is known for manufacturing the Implantable Collamer® Lens (ICL), a significant product in the eye care industry [1] Regulatory Summary - The waiting period under the Hart-Scott-Rodino Antitrust Improvements Act expired at 11:59 p.m. ET on September 29, 2025, allowing Alcon to move forward with the acquisition of STAAR [1]